Assayed Bovine Multi-Sera Level 1, Model No. AL1027
FDA Device Recall #Z-2207-2019 — Class III — June 10, 2019
Recall Summary
| Recall Number | Z-2207-2019 |
| Classification | Class III — Low risk |
| Date Initiated | June 10, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Randox Laboratories, Limited |
| Location | Crumlin, N/A |
| Product Type | Devices |
| Quantity | 4 kits (US) |
Product Description
Assayed Bovine Multi-Sera Level 1, Model No. AL1027
Reason for Recall
The firm is re-assigning the Mean of all Instruments target and range for Bile Acids (5th Generation Colorimetric) in the Assayed Bovine Multi-Sera Level 1 Control Lot 205SL.
Distribution Pattern
Domestic distribution to Arizona, Oregon, Washington, and West Virginia. Foreign distribution to Australia, Belarus, Canada, France, Germany, Ireland, Kenya, Korea, Lithuania, New Zealand, Nigeria, Oman, Russia, Singapore, South Africa, Sweden, Switzerland, Turkey, and UK.
Lot / Code Information
205SL
Other Recalls from Randox Laboratories, Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1018-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (I... | Dec 20, 2024 |
| Z-1017-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (... | Dec 20, 2024 |
| Z-1349-2020 | Class II | RX Daytona Plus (with ISE/without ISE); Models ... | Dec 19, 2019 |
| Z-0414-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
| Z-0412-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.